Armlogi Appoints Sheng-Kai Hsu as CFO-March 2024-www.financetom.com

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Armlogi Appoints Sheng-Kai Hsu as CFO

Jan 14, 2025 1:57 PM

04:16 PM EST, 01/14/2025 (MT Newswires) -- Armlogi ( BTOC ) appointed Sheng-Kai Hsu as chief financial officer.

Hsu succeeds Zhiliang Zhou, who will continue in an advisory capacity, Armlogi ( BTOC ) said Tuesday in a statement.

Hsu joined Armlogi ( BTOC ) in July as accounting lead.

Previous page： Nadav Zafrir to take over as CEO of Israel's Check Point Next page： Lockmaker Allegion raises profit forecast on strong demand from commercial markets

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Nadav Zafrir to take over as CEO of Israel's Check Point

Jul 24, 2024

JERUSALEM, July 24 (Reuters) - Check Point Software Technologies ( CHKP ) on Wednesday said that industry veteran Nadav Zafrir will become its new chief executive starting in December. Gil Shwed, current CEO and founder, will become executive chairman, it said. Zafrir will join Check Point's board of directors pending shareholder approval. The Israeli-based company reported estimate-beating second- quarter results...

Lockmaker Allegion raises profit forecast on strong demand from commercial markets

Jul 24, 2024

July 24 (Reuters) - Allegion ( ALLE ) raised its 2024 adjusted profit forecast on Wednesday, anticipating strong demand for its security systems in commercial buildings. The company, which manufactures security doors, automated entrance solutions, electronic locks, among others, now expects its full-year adjusted profit to be between $7.15 and $7.30 per share, compared with its earlier forecast of $7...

Biogen and Sage's neurological disorder drug fails in mid-stage trial

Jul 24, 2024

July 24 (Reuters) - Biogen and Sage Therapeutics' ( SAGE ) neurological disorder drug failed in a mid-stage trial, the companies said on Wednesday. ...

Deutsche Bank Swings to Q2 Loss, Revenue Increases

Jul 24, 2024

06:36 AM EDT, 07/24/2024 (MT Newswires) -- Deutsche Bank ( DB ) on Wednesday swung to a Q2 loss of 0.28 euros ($0.30) per diluted share from earnings of 0.19 euros a year earlier. Analysts polled by Capital IQ expected earnings of 0.59 euros. Revenue for the quarter ended June 30 was 7.59 billion euros, up from 7.41 billion euros...